Search Results - "Smitt, Peter A.E."

The clinical spectrum of Caspr2 antibody–associated disease by van Sonderen, Agnes, Ariño, Helena, Petit-Pedrol, Mar, Leypoldt, Frank, Körtvélyessy, Peter, Wandinger, Klaus-Peter, Lancaster, Eric, Wirtz, Paul W, Schreurs, Marco W.J, Sillevis Smitt, Peter A.E, Graus, Francesc, Dalmau, Josep, Titulaer, Maarten J

“…OBJECTIVE:To report a large cohort of patients with antibodies against contactin-associated protein-like 2 (Caspr2) and provide the clinical spectrum of this…”
Get full text

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis by de Bruijn, Marienke A.A.M, van Sonderen, Agnes, van Coevorden-Hameete, Marleen H, Bastiaansen, Anna E.M, Schreurs, Marco W.J, Rouhl, Rob P.W, van Donselaar, Cees A, Majoie, Marian H.J.M, Neuteboom, Rinze F, Sillevis Smitt, Peter A.E, Thijs, Roland D, Titulaer, Maarten J

“…OBJECTIVEThis nationwide cohort study evaluates seizure responses to immunotherapy and antiepileptic drugs (AEDs) in patients with anti-leucine-rich…”
Get full text

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis by de Bruijn, Marienke A.A.M, Aarsen, Femke K, van Oosterhout, Marielle P, van der Knoop, Marieke M, Catsman-Berrevoets, Coriene E, Schreurs, Marco W.J, Bastiaansen, Danielle E.M, Sillevis Smitt, Peter A.E, Neuteboom, Rinze F, Titulaer, Maarten J

“…OBJECTIVETo provide detailed long-term outcome data of children and adolescents following pediatric anti-N-methyl-D-aspartate receptor (anti-NMDAR)…”
Get full text

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies by van Sonderen, Agnes, Schreurs, Marco W.J, de Bruijn, Marienke A.A.M, Boukhrissi, Sanae, Nagtzaam, Mariska M.P, Hulsenboom, Esther S.P, Enting, Roelien H, Thijs, Roland D, Wirtz, Paul W, Sillevis Smitt, Peter A.E, Titulaer, Maarten J

“…OBJECTIVE:To assess the clinical relevance of a positive voltage-gated potassium channel (VGKC) test in patients lacking antibodies to LGI1 and Caspr2…”
Get full text

Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology by GRAVENDEEL, Lonneke A. M, KOUWENHOVEN, Mathilde C. M, DE MOOR, Bart, EILERS, Paul H. C, VAN DER SPEK, Peter J, KROS, Johan M, SILLEVIS SMITT, Peter A. E, VAN DEN BENT, Martin J, FRENCH, Pim J, GEVAERT, Olivier, DE ROOI, Johan J, STUBBS, Andrew P, ELZA DUIJM, J, DAEMEN, Anneleen, BLEEKER, Fonnet E, BRALTEN, Linda B. C, KLOOSTERHOF, Nanne K

“…Gliomas are the most common primary brain tumors with heterogeneous morphology and variable prognosis. Treatment decisions in patients rely mainly on…”
Get full text

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal by Oldenmenger, Wendy H, Sillevis Smitt, Peter A.E, van Dooren, Silvia, Stoter, Gerrit, van der Rijt, Carin C.D

“…Abstract The aim of this paper is to identify the major barriers hindering adequate pain management and critically review interventions aiming to overcome…”
Get full text

A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951 by VAN DEN BENT, Martin J, GRAVENDEEL, Lonneke A, FRENCH, Pim J, GORLIA, Thierry, KROS, Johan M, LAPRE, Lariesa, WESSELING, Pieter, TEEPEN, Johannes L, IDBAIH, Ahmed, SANSON, Marc, SILLEVIS SMITT, Peter A. E

“…The MGMT promoter methylation status has been suggested to be predictive for outcome to temozolomide chemotherapy in patients with glioblastoma (GBM)…”
Get full text

SOX Antibodies in Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: Frequency and Relation With Survival by TITULAER, Maarten J, KLOOSTER, Rinse, VAN DER MAAREL, Silvère M, VERSCHUUREN, Jan J. G. M, POTMAN, Marko, SABATER, Lidia, GRAUS, Francesc, HEGEMAN, Ingrid M, THIJSSEN, Peter E, WIRTZ, Paul W, TWIJNSTRA, Albert, SILLEVIS SMITT, Peter A. E

“…SOX1 antibodies are common in small-cell lung carcinoma (SCLC) with and without paraneoplastic syndrome (PNS) and can serve as serological tumor marker…”
Get full text

Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS by TITULAER, Maarten J, MADDISON, Paul, ROEP, Bart O, VINCENT, Angela, VAN DER MAAREL, Silvère M, GERT VAN DIJK, J, LANG, Bethan, VERSCHUUREN, Jan J. G. M, SONT, Jacob K, WIRTZ, Paul W, HILTON-JONES, David, KLOOSTER, Rinse, WILLCOX, Nick, POTMAN, Marko, SILLEVIS SMITT, Peter A. E, KUKS, Jan B. M

“…Approximately one half of patients with Lambert-Eaton myasthenic syndrome (LEMS) have small-cell lung carcinomas (SCLC), aggressive tumors with poor prognosis…”
Get full text

Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up by van Sonderen, Agnes, Thijs, Roland D, Coenders, Elias C, Jiskoot, Lize C, Sanchez, Esther, de Bruijn, Marienke A.A.M, van Coevorden-Hameete, Marleen H, Wirtz, Paul W, Schreurs, Marco W.J, Sillevis Smitt, Peter A.E, Titulaer, Maarten J

“…OBJECTIVE:This nationwide study gives a detailed description of the clinical features and long-term outcome of anti–leucine-rich glioma-inactivated 1 (LGI1)…”
Get full text

The Effects of Analgesic Prescription and Patient Adherence on Pain in a Dutch Outpatient Cancer Population by Enting, Roelien H., MD, Oldenmenger, Wendy H., MSc, Van Gool, Arthur R., MD, van der Rijt, Carin C.D., MD, Sillevis Smitt, Peter A.E., MD

“…Abstract Insufficient awareness of cancer pain, including breakthrough pain, inadequate analgesic prescriptions, and nonadherence contribute to inadequate…”
Get full text

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial by Erdem-Eraslan, Lale, van den Bent, Martin J, Hoogstrate, Youri, Naz-Khan, Hina, Stubbs, Andrew, van der Spek, Peter, Böttcher, René, Gao, Ya, de Wit, Maurice, Taal, Walter, Oosterkamp, Hendrika M, Walenkamp, Annemiek, Beerepoot, Laurens V, Hanse, Monique C J, Buter, Jan, Honkoop, Aafke H, van der Holt, Bronno, Vernhout, René M, Sillevis Smitt, Peter A E, Kros, Johan M, French, Pim J

“…The results from the randomized phase II BELOB trial provided evidence for a potential benefit of bevacizumab (beva), a humanized monoclonal antibody against…”
Get full text

Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma by Iorio, Raffaele, Damato, Valentina, Mirabella, Massimiliano, Vita, Maria Gabriella, Hulsenboom, Esther, Plantone, Domenico, Bizzarro, Alessandra, Del Grande, Alessandra, Sillevis Smitt, Peter A.E

“…Abstract Subacute cerebellar degeneration associated with metabotropic glutamate receptor type 1 (mGluR1) autoantibodies is an uncommon syndrome known to be…”
Get full text

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives by Weenink, Bas, French, Pim J, Sillevis Smitt, Peter A E, Debets, Reno, Geurts, Marjolein

“…Glioblastomas are aggressive, fast-growing primary brain tumors. After standard-of-care treatment with radiation in combination with temozolomide, the overall…”
Get full text

Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy by Bastiaansen, Anna E.M., de Bruijn, Marienke A.A.M., Schuller, Sabine L., Martinez-Hernandez, Eugenia, Brenner, Juliëtte, Paunovic, Manuela, Crijnen, Yvette S., Mulder, Maxim J.H.L., Schreurs, Marco W.J., de Graaff, Esther, Smitt, Peter A.E., Neuteboom, Rinze F., de Vries, Juna M., Titulaer, Maarten J.

“…To describe the clinical features of anti-NMDAR encephalitis, emphasizing on late-onset patients and antibody test characteristics in serum and CSF. Nationwide…”
Get full text

Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis by de Bont, Judith M, Kros, Johan M, Passier, Monique M C J, Reddingius, Roel E, Sillevis Smitt, Peter A E, Luider, Theo M, den Boer, Monique L, Pieters, Rob

“…The objective of this study was to identify differentially expressed and prognostically important genes in pediatric medulloblastoma and pediatric ependymoma…”
Get full text

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951 by ERDEM-ERASLAN, Lale, GRAVENDEEL, Lonneke A, KROS, Johan M, GORLIA, Thierry, VAN DEN BENT, Martin J, FRENCH, Pim J, DE ROOI, Johan, EILERS, Paul H. C, IDBAIH, Ahmed, SPLIET, Wim G. M, DEN DUNNEN, Wilfred F. A, TEEPEN, Johannes L, WESSELING, Pieter, SILLEVIS SMITT, Peter A. E

“…Intrinsic glioma subtypes (IGSs) are molecularly similar tumors that can be identified based on unsupervised gene expression analysis. Here, we have evaluated…”
Get full text

Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples by Stoop, Marcel P., Coulier, Leon, Rosenling, Therese, Shi, Shanna, Smolinska, Agnieszka M., Buydens, Lutgarde, Ampt, Kirsten, Stingl, Christoph, Dane, Adrie, Muilwijk, Bas, Luitwieler, Ronald L., Sillevis Smitt, Peter A.E., Hintzen, Rogier Q., Bischoff, Rainer, Wijmenga, Sybren S., Hankemeier, Thomas, van Gool, Alain J., Luider, Theo M.

“…The analysis of cerebrospinal fluid (CSF) is used in biomarker discovery studies for various neurodegenerative central nervous system (CNS) disorders. However,…”
Get full text

Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data by van Hijfte, Levi, Geurts, Marjolein, Vallentgoed, Wies R., Eilers, Paul H.C., Sillevis Smitt, Peter A.E., Debets, Reno, French, Pim J.

“…Spatial transcriptomics is a novel technique that provides RNA-expression data with tissue-contextual annotations. Quality assessments of such techniques using…”
Get full text

antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions by Dekker, Lennard J. M, Zeneyedpour, Lona, Brouwer, Eric, van Duijn, Martijn M, Sillevis Smitt, Peter A. E, Luider, Theo M

“…Autoantibodies are increasingly used as biomarkers in the detection of autoimmune disorders and cancer. Disease specific antibodies are generally detected by…”
Get full text